Honour

What Honour does

Honour Lab Limited is an India-based small-molecule Contract Development and Manufacturing Organization (CDMO) headquartered in Hyderabad, with manufacturing operations in Hyderabad, Pune, and Visakhapatnam. Founded in 2011, the company operates eight cGMP-certified manufacturing facilities with a combined installed reactor capacity of 5,000 m³ across 500+ reactors ranging from 10L to 20,000L, plus a 75,000 ft² R&D center staffed by 300+ scientists. The company holds approvals from FDA, EU-GMP, PMDA, ANVISA, TGA, WHO, and EDQM, and has filed 361 Drug Master Files serving 300+ customers across 50+ countries.

The company's service portfolio spans the full small-molecule drug substance lifecycle: route scouting and process development, analytical method development and validation, GMP manufacturing for Phase I-III clinical trials, and commercial-scale API production (both New Chemical Entities and generics). Specialized chemistry capabilities include high-volume fluorination, continuous flow chemistry (with demonstrated nitration at 50 kg scale), large-scale asymmetric synthesis and chiral resolution, nucleoside synthesis for oligonucleotides, and commercial-scale biocatalysis. Beyond pharmaceutical CDMO services, Honour produces specialty chemicals (phosphoramidites, reagents such as 1,1'-Carbonyldiimidazole and EDC HCl, excipients including Sodium Stearyl Fumarate and Salcaprozate Sodium) for electronics, agrochemical, and high-performance materials applications through its Honour Specialty division.

Revenue is generated primarily through fee-for-service CDMO engagements with global pharmaceutical and biotechnology companies, supported by direct enterprise sales and dedicated project management. Pricing is project-based and not publicly disclosed, with multi-year contracts typical. The company follows a customer-centric GTM model with dedicated Project Managers coordinating cross-functional teams across preclinical, clinical, and commercial phases. In 2025, Honour expanded capacity with a new state-of-the-art Honour Synthesis facility in Hyderabad (~40,234 m²) and made three senior CDMO leadership appointments, signaling a growth-phase operating posture. The company remains privately held with no disclosed venture or private equity funding, with ownership concentrated among the founding management team.

Name

Honour

Legal name

Honour Lab Limited

Website

https://honourlab.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Honour Lab Limited is a privately held, India-based small-molecule CDMO headquartered in Hyderabad, offering end-to-end drug substance development and manufacturing services across eight cGMP facilities, serving 300+ global pharmaceutical, electronics, and agrochemical customers in 50+ countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical CDMO Services

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412), Scientific Research and Development Services (5417)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Small-Molecule API & Intermediates CDMO (HLAGABAA)

akta.pro secondary industries

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM), Drug Substance–Drug Product Integrated CDMO (HLAGABAG)

Keywords

• Pharmaceutical CDMO services
• Contract development manufacturing
• API manufacturing
• Specialty chemicals
• Custom synthesis

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. CDMO Services - Process & Analytical Development: Fee-for-service model providing process scouting, optimization, method development and validation, impurity profiling, stability studies, and process safety evaluation from preclinical through commercial phases.
2. cGMP Manufacturing: Manufacturing services for clinical trials (Phase I-III) and commercial production including API manufacturing (NCEs and Generic APIs), regulatory starting materials, intermediates, excipients, and phosphoramidites. Scale from 10L to 20,000L reactor volumes.
3. Custom Synthesis - Specialty Chemicals: Tailored synthesis solutions for organic compounds serving pharmaceutical, electronics, and specialty chemicals industries. Full lifecycle support from R&D to commercial production from milligram to metric ton level.
4. Pharmaceutical Ingredients and Excipients: Manufacturing and supply of pharmaceutical ingredients including reagents (1,1'-Carbonyldiimidazole, EDC HCl, DSC, NHS), excipients (Sodium Stearyl Fumarate, Salcaprozate Sodium, Glycine HCl) for drug formulations.
5. API Manufacturing: High-quality Active Pharmaceutical Ingredient (API) manufacturing with global regulatory compliance. 361 DMFs filed worldwide, serving 300+ customers globally across 50+ countries.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels8 records

Core offering

Honour is a Contract Development and Manufacturing Organization (CDMO) that provides end-to-end small molecule pharmaceutical services from preclinical process and analytical development through cGMP manufacturing of APIs, intermediates, regulatory starting materials, excipients, and phosphoramidites for global pharmaceutical, biotechnology, electronics, and agrochemical customers. The company operates eight cGMP-certified facilities with 5,000 m³ installed capacity and a 75,000 ft² R&D center staffed by 300+ scientists. Revenue is generated through fee-for-service CDMO engagements, custom synthesis contracts, and product sales of APIs, reagents, and specialty chemicals.

Product overview

Honour is a Small Molecule CDMO (Contract Development and Manufacturing Organization) offering an integrated portfolio of pharmaceutical manufacturing services and specialty chemicals. The core offering consists of Small Molecule CDMO Services encompassing Process & Analytical Development, Custom Synthesis, GMP Manufacturing, and Research & Development capabilities. Product portfolio includes Active Pharmaceutical Ingredients (APIs), Reagents (1,1'-Carbonyldiimidazole, EDC HCl, N,N'-Disuccinimidyl carbonate, N-Hydroxysuccinimide), Excipients (Sodium Stearyl Fumarate, Salcaprozate Sodium, Glycine HCl), and Specialty Chemicals including Phosphoramidites for oligonucleotide synthesis. The company operates 8 manufacturing facilities and a 75,000 ft² R&D center across Hyderabad, Pune, and Visakhapatnam, India, serving pharmaceutical, electronics, agrochemical, and high-performance materials industries globally.

Differentiator

Problem solved

Functional benefit

Brands

• Honour Specialty: Division delivering high-quality, customized solutions for specialty chemicals serving pharmaceuticals, electronics, agrochemicals, and high-performance materials industries.
• Honour Synthesis

Products and services

• Small Molecule CDMO Services End-to-end Contract Development and Manufacturing Organization services for small molecule pharmaceuticals, covering preclinical to commercial manufacturing phases with GMP-certified facilities.
• Process & Analytical Development Comprehensive process chemistry and analytical solutions including route scouting, process optimization, method development and validation, impurity profiling, GTI/nitrosamine assessment, structural elucidation, and stability studies.
• Custom Synthesis Tailored synthesis solutions for organic compounds serving pharmaceutical, electronics, and specialty chemicals industries, supporting projects from milligram to metric ton scale.
• GMP Manufacturing cGMP-certified manufacturing services for clinical trials (Phase I-III) and commercial production, with capabilities across regulatory starting materials, intermediates, excipients, phosphoramidites, and APIs.
• Specialty Chemicals Customized specialty chemicals for pharmaceuticals, electronics (semiconductors, conductive polymers, energy systems, display technologies), agrochemicals, and high-performance materials sectors.
• Active Pharmaceutical Ingredients (APIs) High-quality Active Pharmaceutical Ingredients (APIs) manufactured under stringent global standards, serving therapeutic categories including diabetes, cardiovascular, respiratory, neurology, gastroenterology, immunology, urology, ophthalmology, and hematology.
• Reagents Specialized pharmaceutical reagents including 1,1'-Carbonyldiimidazole (CAS: 530-62-1), EDC HCl (CAS: 25952-53-8), N,N'-Disuccinimidyl carbonate (CAS: 74124-79-1), and N-Hydroxysuccinimide (CAS: 6066-82-6) for amide coupling and peptide synthesis.
• Excipients cGMP-manufactured pharmaceutical excipients including Sodium Stearyl Fumarate (CAS: 4070-80-8), Salcaprozate Sodium (CAS: 203787-91-1), and Glycine HCl (CAS: 6000-43-7) for drug formulations.
• Phosphoramidites Specialized phosphoramidite products for oligonucleotide synthesis, supported by the company's Peptides and Custom Amidites brochure offerings.
• Research & Development Services State-of-the-art R&D services including 75,000 ft² facilities, 300+ scientists, kilo lab, and pilot plant for process development from early-phase to commercial scale.

Quantifiable outcome

• 361 DMFs filed worldwide demonstrating regulatory compliance track record
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Laurus Labs: Indian API and CDMO provider with global regulatory approvals. Similar therapeutic-area exposure and small-molecule focus.
• Piramal Pharma Solutions: Global CDMO offering API development and manufacturing across multiple sites. Direct competitor in small-molecule API CDMO with comparable multi-regulatory footprint.
• Syngene International: India-based CRO/CDMO offering end-to-end small-molecule development and manufacturing services for global pharma. Comparable scale, business model, and customer base to Honour.
• Suven Pharmaceuticals: Indian CDMO specializing in API development and manufacturing for NCEs and generics. Comparable small-molecule focus and customer base.
• Divis Laboratories: Indian manufacturer of APIs and intermediates with global compliance. Comparable in scale, regulatory approvals, and customer base.
• Sai Life Sciences: India-based CDMO focused on small-molecule API and intermediates, serving global pharma. Closely comparable in customer profile, regulatory approvals, and capacity.

Broad incumbents

• Aurobindo Pharma: Large Indian pharmaceutical manufacturer with API and CDMO operations. Overlaps with Honour in API manufacturing for regulated markets.
• Catalent: Global CDMO providing drug substance and drug product services. Competes with Honour in small-molecule CDMO while also offering biologics and softgel capabilities.
• Lonza: Global CDMO leader across small molecules, biologics, and cell & gene therapy. Overlaps with Honour in small-molecule API manufacturing, but operates at much larger scale and broader scope.

Emerging players

• Neuland Laboratories: Indian CDMO focused on API development and manufacturing. Smaller in scale than Honour but comparable in service offering and regulatory focus.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInin.linkedin.com/company/honour-lab-limited
• Facebookfacebook.com/profile.php

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Honour